Skip to main content

Table 2 Multivariate logistics analysis for miR-361-5p in ACS patients

From: Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients

Features

Multivariate logistics analysis

 

OR

95% CI

P value

Age

1.228

0.792–1.761

0.742

Gender

1.122

0.807–1.851

0.856

BMI

1.608

0.897–2.341

0.224

TC

1.841

0.908–2.622

0.168

TG

1.908

0.966–3.121

0.077

HDL-C

1.934

0.971–3.257

0.065

LDL-C

2.019

0.982–3.345

0.057

Hypertension

1.755

0.928–2.626

0.234

Diabetes

1.798

0.951–2.974

0.097

WBC

1.713

0.913–2.596

0.276

cTnI

1.858

1.098–2.801

0.047*

Gensini score

2.225

1.749–2.917

0.018*

Drug therapy

   

 Antiplatelet therapy

1.371

0.785–2.117

0.457

 Nitrates

1.108

0.804–1.598

0.895

 ACEI/ARB

1.152

0.776–1.853

0.524

 Statins

1.214

0.781–1.779

0.661

 β-blockers

1.089

0.628–1.597

0.735

miR-361-5p

2.485

1.999–3.208

0.012*

  1. miR-361-5p microRNA-361-5p, ACS acute coronary syndrome, OR odds ratio, CI confidence interval, BMI body mass index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, WBC white blood cell, cTnI cardiac troponin I, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker
  2. *P < 0.05